差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 Angion Biomedica Corp. - ANGN CFD

0.4885
7.95%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.0630
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 0.5307
開盤價* 0.5275
1 年變化* -74.52%
日範圍* 0.4885 - 0.5276
52 周範圍 0.46-2.40
平均交易量（10 天） 23.95K
平均交易量（3 個月） 1.41M
市值 16.26M
市盈率 -100.00K
流通股 30.11M
收入 2.30M
EPS -1.29
股息（收益率 %） N/A
貝塔 -100.00K
下一個財報發布日期 Mar 28, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 24, 2023 0.4885 -0.0390 -7.39% 0.5275 0.5276 0.4884
Mar 23, 2023 0.5307 0.0028 0.53% 0.5279 0.5374 0.5238
Mar 22, 2023 0.4887 0.0096 2.00% 0.4791 0.4890 0.4791
Mar 21, 2023 0.4789 0.0248 5.46% 0.4541 0.4791 0.4493
Mar 20, 2023 0.4881 0.0001 0.02% 0.4880 0.4986 0.4739
Mar 17, 2023 0.4887 -0.0490 -9.11% 0.5377 0.5378 0.4823
Mar 16, 2023 0.5081 0.0198 4.05% 0.4883 0.5695 0.4883
Mar 15, 2023 0.4930 -0.0542 -9.90% 0.5472 0.5671 0.4888
Mar 14, 2023 0.5372 -0.0196 -3.52% 0.5568 0.5963 0.5372
Mar 13, 2023 0.5377 -0.0240 -4.27% 0.5617 0.5621 0.5208
Mar 10, 2023 0.5132 -0.0641 -11.10% 0.5773 0.5778 0.5054
Mar 9, 2023 0.5568 -0.0604 -9.79% 0.6172 0.6256 0.5375
Mar 8, 2023 0.5960 0.0078 1.33% 0.5882 0.6158 0.5882
Mar 7, 2023 0.6060 -0.0094 -1.53% 0.6154 0.6155 0.6056
Mar 6, 2023 0.6256 -0.0208 -3.22% 0.6464 0.6466 0.6079
Mar 3, 2023 0.6156 0.0290 4.94% 0.5866 0.6258 0.5865
Mar 2, 2023 0.5969 0.0009 0.15% 0.5960 0.6130 0.5960
Mar 1, 2023 0.5883 -0.0370 -5.92% 0.6253 0.6256 0.5855
Feb 28, 2023 0.6258 0.0006 0.10% 0.6252 0.6452 0.6252
Feb 27, 2023 0.6453 0.0001 0.02% 0.6452 0.6454 0.6451

Angion Biomedica Corp. Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018
總收入 28.312 2.88 1.487 4.029
收入 28.312 2.88 1.487 4.029
收入成本，共計 0.433 1.19 0.64 0.378
毛利 27.879 1.69 0.847 3.651
總營業費用 66.714 58.153 40.078 18.371
銷售/一般/行政費用，總計 18.488 17.986 9.601 5.391
研究與開發 48.698 38.977 29.837 12.602
營業收入 -38.402 -55.273 -38.591 -14.342
利息收入（費用），非經營淨值 -2.191 -8.249 0.488 0.401
其他，淨值 -13.98 -16.527 -2.555 -6.084
稅前淨收入 -54.573 -80.107 -40.658 -20.025
稅後淨收入 -54.573 -80.107 -40.658 -20.025
未計算非常項目前的淨收益 -54.573 -80.107 -40.658 -20.025
淨收入 -54.573 -80.107 -40.658 -20.025
Total Adjustments to Net Income 0 -4.98
普通股股東可獲收益 (不含非經常性項目) -54.573 -80.107 -40.658 -25.005
普通股股東可獲收益 (含非經常性項目) -54.573 -80.107 -40.658 -25.005
攤薄淨收入 -54.573 -80.107 -40.658 -25.005
攤薄後加權平均股 28.2448 14.7621 9.97635 9.97635
扣除特別項目的每股攤薄盈利 -1.93214 -5.42652 -4.07544 -2.50643
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -1.96418 -5.4226 -4.07544 -2.50643
Gain (Loss) on Sale of Assets 0 -0.058
異常費用（收入） -0.905
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 1.648 25.941 1.46 0.54 0.371
收入 1.648 25.941 1.46 0.54 0.371
收入成本，共計 0.433 0 0 0
毛利 25.508 1.46 0.54 0.371
總營業費用 16.133 11.307 17.218 17.879 20.31
銷售/一般/行政費用，總計 4.466 4.206 3.93 4.34 6.012
研究與開發 11.667 6.668 13.288 14.444 14.298
營業收入 -14.485 14.634 -15.758 -17.339 -19.939
利息收入（費用），非經營淨值 0.206 -0.016 -0.074 0.067 -2.168
其他，淨值 0.039 0.272 0.128 0.2 -14.58
稅前淨收入 -14.24 14.89 -15.704 -17.072 -36.687
稅後淨收入 -14.24 14.89 -15.704 -17.072 -36.687
未計算非常項目前的淨收益 -14.24 14.89 -15.704 -17.072 -36.687
淨收入 -14.24 14.89 -15.704 -17.072 -36.687
普通股股東可獲收益 (不含非經常性項目) -14.24 14.89 -15.704 -17.072 -36.687
普通股股東可獲收益 (含非經常性項目) -14.24 14.89 -15.704 -17.072 -36.687
攤薄淨收入 -14.24 14.89 -15.704 -17.072 -36.687
攤薄後加權平均股 29.9592 29.9654 29.8296 29.6703 23.4438
扣除特別項目的每股攤薄盈利 -0.47531 0.49691 -0.52646 -0.57539 -1.56489
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.47531 0.49691 -0.52646 -0.60589 -1.56489
異常費用（收入） 0 0 -0.905
Gain (Loss) on Sale of Assets 0
  • 年度
  • 每季度
2021 2020 2019 2018
流動資産總額 91.247 42.297 6.106 25.679
現金和短期投資 88.756 34.607 5.571 25.512
現金等價物 88.756 34.607 5.571 25.512
應收賬款總額，淨額 0.806 5 0.44 0.107
Prepaid Expenses 1.031 0.352 0.095 0.06
Total Assets 96.513 47.347 11.886 26.628
Property/Plant/Equipment, Total - Net 4.437 4.228 4.781 0.017
Property/Plant/Equipment, Total - Gross 4.954 4.654 5.109 0.295
Accumulated Depreciation, Total -0.517 -0.426 -0.328 -0.278
Long Term Investments 0.723 0.822 0.999 0.932
Total Current Liabilities 11.296 107.449 26.575 7.355
Accounts Payable 4.71 5.578 11.239 0.534
Accrued Expenses 4.113 7.276 3.694 2.98
Notes Payable/Short Term Debt 0 51.43 5.848 0
Other Current Liabilities, Total 2.415 43.165 5.794 3.841
Total Liabilities 15.006 137.796 30.472 7.717
Total Long Term Debt 0.235 0.635 0 0
Other Liabilities, Total 3.475 29.712 3.897 0.362
Total Equity 81.507 -90.449 -18.586 18.911
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.3 0.156 0.095 0.094
Additional Paid-In Capital 296.445 72.136 63.584 60.138
Retained Earnings (Accumulated Deficit) -215.135 -160.562 -80.455 -39.797
Treasury Stock - Common 0 -1.846 -1.81 -1.524
Total Liabilities & Shareholders’ Equity 96.513 47.347 11.886 26.628
Total Common Shares Outstanding 29.9591 15.3167 9.97635 9.97635
Other Current Assets, Total 0.654 2.338
Long Term Debt 0 0.635
Other Equity, Total -0.103 -0.333
Other Long Term Assets, Total 0.106
Current Port. of LT Debt/Capital Leases 0.058
Capital Lease Obligations 0.235
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 76.239 91.247 104.393 119.702 133.498
現金和短期投資 73.002 88.756 102.736 117.313 130.456
現金等價物 73.002 88.756 102.736 117.313 130.456
應收賬款總額，淨額 0 0.806 0 0 0
Prepaid Expenses 0.021 1.031 1.018 1.761 2.343
Other Current Assets, Total 3.216 0.654 0.639 0.628 0.699
Total Assets 81.258 96.513 109.94 125.359 139.2
Property/Plant/Equipment, Total - Net 4.209 4.437 4.652 4.776 4.787
Property/Plant/Equipment, Total - Gross 4.758 4.954 5.137 5.231 5.219
Accumulated Depreciation, Total -0.549 -0.517 -0.485 -0.455 -0.432
Long Term Investments 0.732 0.723 0.862 0.843 0.877
Other Long Term Assets, Total 0.078 0.106 0.033 0.038 0.038
Total Current Liabilities 10.381 11.296 17.946 20.524 16.963
Accounts Payable 3.433 4.71 7.679 9.307 6.69
Accrued Expenses 6.16 4.113 6.219 5.522 4.872
Notes Payable/Short Term Debt 0 0 0 0 0.895
Other Current Liabilities, Total 0.728 2.415 4.048 5.695 4.506
Total Liabilities 14.056 15.006 45.426 48.17 46.757
Total Long Term Debt 0.219 0.235 0 0 0
Long Term Debt 0 0 0 0
Other Liabilities, Total 3.456 3.475 27.48 27.646 29.794
Total Equity 67.202 81.507 64.514 77.189 92.443
Common Stock 0.3 0.3 0.304 0.303 0.3
Additional Paid-In Capital 296.476 296.445 298.518 295.636 292.67
Retained Earnings (Accumulated Deficit) -229.375 -215.135 -230.025 -214.321 -197.249
Treasury Stock - Common 0 -4.21 -4.21 -2.991
Other Equity, Total -0.199 -0.103 -0.073 -0.219 -0.287
Total Liabilities & Shareholders’ Equity 81.258 96.513 109.94 125.359 139.2
Total Common Shares Outstanding 29.9594 29.9591 29.9331 29.7976 29.6605
Current Port. of LT Debt/Capital Leases 0.06 0.058
Capital Lease Obligations 0.219 0.235
  • 年度
  • 每季度
2021 2020 2019 2018
淨收入/起跑線 -54.573 -80.107 -40.658 -20.025
經營活動産生的現金 -52.643 -22.888 -24.589 -8.02
經營活動産生的現金 0.091 0.098 0.05 0.002
非現金物品 27.809 31.352 6.269 9.051
Cash Taxes Paid 0 0
已付現金利息 0.007 0 0
營運資金的變化 -25.97 25.769 9.75 2.952
投資活動産生的現金 -0.382 -0.041 -0.242 0
資本支出 -0.382 -0.041 -0.242 0
融資活動産生的現金 107.171 52.409 4.89 31.741
股票的發行（報廢），淨額 -0.617 20.813 -0.375 28.596
債務的發行（退還），淨額 0.293 32.118 5.265 3.145
現金淨變化 54.149 29.036 -19.941 23.721
融資現金流項目 107.495 -0.522
外彙效應 0.003 -0.444
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -14.24 -54.573 -69.463 -53.759 -36.687
Cash From Operating Activities -15.653 -52.643 -38.281 -23.082 -12.551
Cash From Operating Activities 0.032 0.091 0.059 0.029 0.006
Non-Cash Items 0.179 27.809 25.729 23.505 21.675
Changes in Working Capital -1.624 -25.97 5.394 7.143 2.455
Cash From Investing Activities 0 -0.382 -0.346 -0.285 -0.041
Capital Expenditures 0 -0.382 -0.346 -0.285 -0.041
Cash From Financing Activities -0.014 107.171 106.767 106.068 108.444
Financing Cash Flow Items 0 107.495 -5.52 -5.428 -2.797
Issuance (Retirement) of Stock, Net 0 -0.617 112.287 111.496 111.241
Issuance (Retirement) of Debt, Net -0.014 0.293 0 0 0
Foreign Exchange Effects -0.087 0.003 -0.011 0.005 -0.003
Net Change in Cash -15.754 54.149 68.129 82.706 95.849
Cash Interest Paid 0.007
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Satterfield (Thomas A Jr) Individual Investor 7.2983 2197825 623278 2022-12-31 LOW
Vifor (International), Ltd Corporation 6.6269 1995643 0 2023-03-15 LOW
EISA-ABC LLC Corporation 5.719 1722237 0 2023-03-15 LOW
Goldberg (Itzhak D) Individual Investor 5.6193 1692199 4213 2023-03-15 LOW
Venkatesan (Jay R) Individual Investor 3.9765 1197498 0 2023-03-15 LOW
BVF Partners L.P. Hedge Fund 3.5574 1071297 0 2022-12-31 LOW
Nantahala Capital Management, LLC Hedge Fund 3.4308 1033145 -32867 2022-12-31 MED
Ganzi (Victor F.) Individual Investor 3.25 978698 0 2023-03-15 LOW
CM Management, LLC Investment Advisor 2.4313 732178 132178 2022-12-31 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1386 644035 675 2022-12-31 LOW
Park West Asset Management LLC Hedge Fund 1.2311 370724 0 2022-12-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.5811 175000 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5593 168436 -451 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4041 121700 -87277 2022-12-31 HIGH
Omenn (Gilbert S) Individual Investor 0.2667 80326 0 2023-03-15 LOW
Millennium Management LLC Hedge Fund 0.2502 75342 -50261 2022-12-31 HIGH
Raymond James & Associates, Inc. Research Firm 0.1992 60000 0 2022-12-31 LOW
Birchview Capital, LP Investment Advisor 0.1806 54392 0 2022-12-31 LOW
Ergoteles Capital Hedge Fund 0.1757 52913 -25944 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1696 51069 1188 2022-12-31 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Biotechnology & Medical Research (NEC)

7-57 Wells Avenue
NEWTON
MASSACHUSETTS 02459
US

收入報表

  • Annual
  • Quarterly

人們也觀看

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多頭倉位隔夜費用 -0.0194%
空頭倉位隔夜費用 -0.0025%
隔夜費時間 21:00 (UTC)
價差 0.03

XRP/USD

0.45 Price
-0.830% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00370

Gold

1,978.85 Price
-0.760% 1D Chg, %
多頭倉位隔夜費用 -0.0179%
空頭倉位隔夜費用 0.0097%
隔夜費時間 21:00 (UTC)
價差 0.30

US100

12,798.80 Price
+0.420% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 3.0

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易